RESEARCH 16. Bodey GP. The emergence of fungi as major hospital pathogens. J Hosp Infect 1988;11 (suppl A):411-26. 17. Borg-von Z, Eiffert MH, Kann M, Ruchel R. Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 com- pared with those in 1991/92 in the University Hospital Gottingen, Ger- many. Mycoses 1993;36:247-53. 18. Harvey RL, Myers JP. Nosocomial fungemia in a large community teach- ing hospital. Arch Intern Med 1987;147:2117-20. 19. Pfaller MA. Epidemiology and control of fungal infections. Clin Infect Dis 1994;19 (suppl 1):S8-13. 20. Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, Rinaldi M, et al. National Epidemiology of Mycoses Survey (NEMIS): variation in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999;29:253-8. 21. Emori TG, Culver DH, Horan TC, Jarvis WR, White JW, Olson DR, et al. National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control 1991;19:19-35. 22. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC defini- tions for nosocomial infections, 1988. Am J Infect Control 1988;16:128- 40. 23. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests-sixth edition. Approved standard M2-A6. Wayne (PA): The Committee; 1998. 24. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard M27-A. Wayne (PA): The Committee; 1997. 25. Hsueh PR, Wu JJ, Lu JJ, Teng LJ, Luh KT. Antimicrobial susceptibilities of clinical isolates of vancomycin-resistant enterococci in Taiwan. J For- mos Med Assoc 1999;98:45-8. 26. Hsueh PR, Teng LJ, Pan HJ, Chen YC, Wang LH, Chang SC, et al. Emer- gence of vancomycin-resistant enterococci at a university hospital in Tai- wan: persistence of multiple species and multiple clones. Infect Control Hosp Epidemiol 1999;20:828-33. 27. Hsueh PR, Teng LJ, Yang PC, Chen YC, Ho SW, Luh KT. Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit. J Clin Microbiol 1998;36:1347-51. 28. Troilet N, Samore MH, Carmeli Y. Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis 1997;25:1094-8. 29. Weber DJ, Raasch R, Rutala WA. Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens. Chest 1999;115:S34-41. 30. Gaynes RP, Culver DH. The National Nosocomial Infections Surveil- lance System: resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 1992;13:10- 14. 31. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National Surveillance of Nosocomial Bloodstream Infection due to Candida albi- cans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis 1998;31:327-32. 32. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996;9:499-511. 33. Iwata K. Drug resistance in human pathogenic fungi. Eur J Epidemiol 1992;8:407-21. 34. Siu LK, Lu PR, Hsueh PR, Lin FM, Chang SC, Luh KT, et al. Bacteremia due to extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1. J Clin Microbiol 1999;37:402-7. Address for correspondence: Kwen-Tay Luh, Department of Laboratory Medi- cine, National Taiwan University Hospital, No. 7 Chung-Shan Road, Taipei 100, Taiwan; fax: 886-2-23224263; e-mail: luhkt@ha.mc.ntu.edu.tw 68 Emerging Infectious Diseases • Vol. 8, No. 1, January 2002